ATX 3 408 -0,3%  Dow 25 122 0,6%  Nasdaq 6 820 0,9%  Euro 1,2294 -0,3% 
ATX P 1 718 -0,3%  EStoxx50 3 442 0,3%  Nikkei 21 893 0,7%  CHF 1,1504 0,0% 
DAX 12 497 0,3%  FTSE100 7 242 -0,1%  Öl 66,9 1,0%  Gold 1 328 -0,3% 

Biogen Aktie [WKN: 789617 / ISIN: US09062X1037]

07.12.2017 22:01:00

Biogen to Present at the Guggenheim 5th Annual Healthcare Conference

Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the Guggenheim 5th Annual Healthcare Conference. The webcast will be live on Wednesday, December 13, 2017 at 12:00 p.m. ET. To access the live webcast, please visit Biogen’s Investors section at An archived version of the webcast will be available following the presentation.

About Biogen
Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics. For more information, please visit Follow us on social media – Twitter, LinkedIn, Facebook, YouTube.

Analysen zu Biogen Inc

mehr Analysen
  • Alle
  • Buy
  • Hold
  • Sell
05.02.18 Biogen Buy Mizuho
26.01.18 Biogen Buy H.C. Wainwright & Co.
25.01.18 Biogen Conviction Buy List Goldman Sachs Group Inc.
25.01.18 Biogen overweight JP Morgan Chase & Co.
24.01.18 Biogen Hold Canaccord Adams

Eintrag hinzufügen

Aktien in diesem Artikel


  • Nachrichten zu Aktien
  • Alle Nachrichten